194 related articles for article (PubMed ID: 9770758)
21. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.
Devillier P; Baccard N; Advenier C
Pharmacol Res; 1999 Jul; 40(1):15-29. PubMed ID: 10378986
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
O'Byrne PM; Gauvreau GM; Murphy DM
J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
[TBL] [Abstract][Full Text] [Related]
23. Leukotrienes in respiratory disease.
McMillan RM
Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
[TBL] [Abstract][Full Text] [Related]
24. [Therapy of bronchial asthma. To fight inflammation].
MMW Fortschr Med; 2005 Feb; 147(8):56. PubMed ID: 18441566
[No Abstract] [Full Text] [Related]
25. [Antileukotrienes in the therapy of bronchial asthma].
Rossi G
Recenti Prog Med; 1998 Dec; 89(12):654-6. PubMed ID: 9951316
[No Abstract] [Full Text] [Related]
26. [Airway diseases--leukotriene antagonist kills two flies with one fly-flap].
MMW Fortschr Med; 2006 Mar; 148(11):66-7. PubMed ID: 16612967
[No Abstract] [Full Text] [Related]
27. [Anti-leukotrienes: a new perspective in treatment of bronchial asthma].
Magnussen H; Richter K; Rabe KF
Pneumologie; 1997 Sep; 51(9):877-84. PubMed ID: 9411442
[No Abstract] [Full Text] [Related]
28. [Leukotriene antagonists against bronchial asthma. Not a replacement for steroids].
MMW Fortschr Med; 1999 Sep; 141(38):56. PubMed ID: 10904622
[No Abstract] [Full Text] [Related]
29. Leukotriene modifiers in asthma management.
Capra V; Rovati GE
IDrugs; 2004 Jul; 7(7):659-66. PubMed ID: 15243868
[TBL] [Abstract][Full Text] [Related]
30. Critical appraisal of antileukotriene use in asthma management.
Polosa R
Curr Opin Pulm Med; 2007 Jan; 13(1):24-30. PubMed ID: 17133121
[TBL] [Abstract][Full Text] [Related]
31. Changes in recommended treatments for mild and moderate asthma.
Redding GJ; Stoloff SW
J Fam Pract; 2004 Sep; 53(9):692-700. PubMed ID: 15353157
[No Abstract] [Full Text] [Related]
32. Antileukotriene therapy. Future directions.
Holgate ST; Sampson AP
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S147-53. PubMed ID: 10673245
[No Abstract] [Full Text] [Related]
33. Pharmacogenetics of asthma.
Palmer LJ; Silverman ES; Weiss ST; Drazen JM
Am J Respir Crit Care Med; 2002 Apr; 165(7):861-6. PubMed ID: 11934710
[No Abstract] [Full Text] [Related]
34. Lipid mediator pathways in the lung: leukotrienes as a new target for the treatment of asthma.
Dahlén SE
Clin Exp Allergy; 1998 Nov; 28 Suppl 5():141-6; discussion 171-3. PubMed ID: 9988460
[TBL] [Abstract][Full Text] [Related]
35. Treating asthma in the older patient: is there a place for leukotriene modifiers?
Grayson MH; Korenblat PE
Drugs Aging; 2006; 23(6):451-9. PubMed ID: 16872230
[TBL] [Abstract][Full Text] [Related]
36. Leukotriene antagonists. Do they offer new hope for asthmatics?
Thien F
Aust Fam Physician; 2000 Jun; 29(6):547-51. PubMed ID: 10863810
[TBL] [Abstract][Full Text] [Related]
37. [The anti-leukotrienes: a new class of drugs to integrate into the therapeutic strategy of asthma].
Fellrath JM; Leuenberger P; Weilenmann C; Spertini F
Rev Med Suisse Romande; 1999 Mar; 119(3):217-26. PubMed ID: 10218418
[TBL] [Abstract][Full Text] [Related]
38. Anti-leukotrienes: a new treatment for asthma.
Barnes PJ
Practitioner; 1998 May; 242(1586):395-9. PubMed ID: 10492951
[No Abstract] [Full Text] [Related]
39. [The role of anti-leukotriene drugs in the management of chronic asthma].
Adachi M; Imai T; Minoguchi K
Arerugi; 1999 Jul; 48(7):683-5. PubMed ID: 10481351
[No Abstract] [Full Text] [Related]
40. The prospects for long-term intervention in asthma with antileukotrienes.
Smith LJ
Clin Exp Allergy; 1998 Nov; 28 Suppl 5():154-63; discussion 171-3. PubMed ID: 9988462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
